{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-090435","form_type":"8-K","ticker":"STIM","cik":"0001227636","company_name":"Neuronetics, Inc.","filed_at":"2023-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.193590+00:00","generated_at":"2026-06-17T06:20:27.956874+00:00","sec_items":["1.01","2.03","7.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Neuronetics amends SLR credit facility to $60M, extends maturity to 2028; provides $6M note to Greenbrook","bullets":["Borrowed $2.5M under Term B; total facility up to $60M ($35M Term A drawn earlier). Maturity extended to March 29, 2028 from Feb 2025.","Interest rate: greater of 3.95% or Daily Simple SOFR + 5.65%; interest-only until March 1, 2026.","Final payment fee of 4.95% of funded principal; prepayment fees of 3%/2%/1% based on timing.","Issued $6M secured promissory note to Greenbrook converting ~$5.9M accounts payable; matures March 31, 2027 at SOFR + 7.65%.","Security interest in Greenbrook's assets pari passu with senior lender; warrants at 20% discount upon default."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-090435","json":"https://secwatch.observer/filing/0001193125-23-090435.json","markdown":"https://secwatch.observer/filing/0001193125-23-090435.md","text":"https://secwatch.observer/filing/0001193125-23-090435.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1227636/000119312523090435/0001193125-23-090435-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1227636/000119312523090435/d482212d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T06:20:27.956874+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8f776f6109aec725fa5753051c6ac64282c847d5","claim":"Neuronetics, Inc. amended credit facility with SLR Investment Corp. at greater of (a) 3.95% or (b) Daily Simple SOFR for a term of one month, plus 5.65 maturing March 29, 2028.","evidence_excerpt":"On March 29, 2023, Neuronetics, Inc. (the “Company”) entered into that certain Fourth Amendment to Loan and Security Agreement (the “Amendment”) with SLR Investment Corp. (formerly known as Solar Capital Ltd.) (“Solar\"), as collateral agent, and the lenders listed on the signature pages thereto (the “Lenders”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1227636/000119312523090435/0001193125-23-090435-index.htm","confidence":0.95,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"credit facility"},{"label":"Counterparty","value":"SLR Investment Corp."},{"label":"Rate","value":"greater of (a) 3.95% or (b) Daily Simple SOFR for a term of one month, plus 5.65"},{"label":"Maturity","value":"March 29, 2028"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"c2c45b69bea08f22cc2384d632b0602e316fcd24","claim":"Neuronetics, Inc. incurred loan of $6,000,000 with TMS Neurohealth Centers Inc. at Daily Simple SOFR plus 7.65% per annum maturing March 31, 2027.","evidence_excerpt":"On March 31, 2023, the Company entered into a Secured Promissory Note and Guaranty Agreement (the “Promissory Note”) with TMS Neurohealth Centers Inc. (the “Maker”) and Greenbrook TMS Inc. and its subsidiaries, excluding the Maker (the “Guarantors\"), in the principal amount of $6,000,000.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1227636/000119312523090435/0001193125-23-090435-index.htm","confidence":0.98,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$6,000,000"},{"label":"Counterparty","value":"TMS Neurohealth Centers Inc."},{"label":"Rate","value":"Daily Simple SOFR plus 7.65% per annum"},{"label":"Maturity","value":"March 31, 2027"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"ea86a3162b8dbc6f56021b81f12f1d6e6d8fb246","claim":"Neuronetics, Inc. incurred term loan of $2.5 million with SLR Investment Corp. at greater of (a) 3.95% or (b) Daily Simple SOFR for a term of one month, plus 5.65 maturing March 29, 2028.","evidence_excerpt":"On March 29, 2023, the Company borrowed an aggregate amount of $2.5 million under the Term B Loan portion of the Solar Facility.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1227636/000119312523090435/0001193125-23-090435-index.htm","confidence":0.98,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"$2.5 million"},{"label":"Counterparty","value":"SLR Investment Corp."},{"label":"Rate","value":"greater of (a) 3.95% or (b) Daily Simple SOFR for a term of one month, plus 5.65"},{"label":"Maturity","value":"March 29, 2028"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"7ce4f13a388d0285955f0e3afd7e6298acf60861","claim":"Neuronetics, Inc. entered into Secured Promissory Note and Guaranty Agreement with TMS Neurohealth Centers Inc. valued at $6,000,000 (effective 2023-03-31).","evidence_excerpt":"On March 31, 2023, the Company entered into a Secured Promissory Note and Guaranty Agreement (the “Promissory Note”) with TMS Neurohealth Centers Inc. (the “Maker”) and Greenbrook TMS Inc. and its subsidiaries, excluding the Maker (the “Guarantors”), in the principal amount of $6,000,000.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1227636/000119312523090435/0001193125-23-090435-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"TMS Neurohealth Centers Inc."},{"label":"Value","value":"$6,000,000"},{"label":"Effective","value":"2023-03-31"}],"fact_type":"material_agreement"},{"claim_id":"c840647e0cb4a49bdc6bd1a17559c0e7371da9c9","claim":"Neuronetics, Inc. amended Fourth Amendment to Loan and Security Agreement with SLR Investment Corp. valued at $60.0 million (effective 2023-03-29).","evidence_excerpt":"On March 29, 2023, Neuronetics, Inc. (the “Company”) entered into that certain Fourth Amendment to Loan and Security Agreement (the “Amendment”) with SLR Investment Corp. (formerly known as Solar Capital Ltd.) (“Solar”), as collateral agent, and the lenders listed on the signature pages thereto (the “Lenders”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1227636/000119312523090435/0001193125-23-090435-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"SLR Investment Corp."},{"label":"Value","value":"$60.0 million"},{"label":"Effective","value":"2023-03-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}